1、 U.S.SECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31,2025 OR TRANSITION REPORT UNDER SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file num
2、ber:000-56263 BIO ESSENCE CORP.(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)California(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)94-3349551(IRS EMPLOYEE IDENTIFICATION NO.)2955 Main Street,Suite 300,Irvine CA 92618(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)(949)706-9966(ISSUER T
3、ELEPHONE NUMBER)Indicate by check mark whether the registrant(1)filed all reports required to be filed by Section 13 or 15(d)of the Exchange Actduring the past 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subjectto such filing requirement
4、s for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site,if any,everyInteractive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)duringthe preceding 12 mo
5、nths(or for such shorter period that the registrant was required to submit and post such files).Yes No Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting company Emerging Growth company If an emerging growth company,indicate by check mark if the registrant has elected not
6、 to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a)of the Exchange Act.Securities registered pursuant to Section 12(b)of the Act:Title of Each Class Trading Symbol Name of Exchange on WhichRegisteredN/A N/A N/A